scholarly journals Rationale for use mefloquine for COVID-19 treatment

Author(s):  
V. A. Otdelenov ◽  
K. B. Mirzaev ◽  
A. V. Dmitriev ◽  
V. V. Poroikov ◽  
D. A. Sychev

Currently, the use of mefloquine in patients with COVID-19 does not have sufficient scientific justification and, given the unfavorable efficacy and safety profile, cannot be considered for routine use in clinical practice.

2003 ◽  
Vol 6 (S1) ◽  
pp. 19-23 ◽  
Author(s):  
Hiroki Kawai ◽  
Atsushi Ohtsu ◽  
Narikazu Boku ◽  
Yasuo Hamamoto ◽  
Fumio Nagashima ◽  
...  

2013 ◽  
Vol 167 (6) ◽  
pp. 2600-2604 ◽  
Author(s):  
Samir M. Said ◽  
Hans D. Esperer ◽  
Kathrin Kluba ◽  
Conrad Genz ◽  
Anne K. Wiedemann ◽  
...  

2012 ◽  
Vol 157 (2) ◽  
pp. 303-304 ◽  
Author(s):  
Samir M. Said ◽  
Hans D. Esperer ◽  
Kathrin Kluba ◽  
Conrad Genz ◽  
Anne K. Wiedemann ◽  
...  

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. TPS156-TPS156 ◽  
Author(s):  
V. Kunzmann ◽  
R. G. Linke ◽  
P. Ruf ◽  
H. Lindhofer ◽  
M. Hennig ◽  
...  

Author(s):  
L Cantarelli ◽  
JA Morales Barrios ◽  
F Gutierrez Nicolas ◽  
S Garcia Gil ◽  
B Del Rosario Garcia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document